Robin Wright insider trades: Vaccitech (VACC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robin reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2023 | VACC | ↑ Buy | 13,750 | $2.66 | $37K | Direct | Jun 1, 2023 (7d) |
| Dec 22, 2021 | VACC | ↑ Buy | 10,000 | $9.97 | $100K | Direct | Dec 23, 2021 (1d) |
| May 4, 2021 | VACC | ↑ Buy | 14,000 | $17.00 | $238K | Direct | May 6, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robin Wright's insider trades
Robin Wright is a director at Vaccitech (VACC). Since May 4, 2021, Robin has reported 3 open-market purchases worth $374K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VACC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.